EVH
Work Here?
Overview
About EVH
Simplify's Rating
Why EVH is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Design
Consumer Goods
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- Q2 2026 revenue rose to $652.5 million, and guidance increased to $2.6-$2.7 billion.
- Evolent signed an imaging contract for 4.5 million lives, starting in Q3 2026.
- A national payer expansion should generate over $200 million annually once launched.
What critics are saying
- Q2 2026 medical expense ratio stayed 95.3%, compressing margins and cash generation.
- StockTitan reported another January 2026 layoff round, signaling ongoing restructuring pressure.
- A federal investor class settlement over Passport Health Plan allegations remains a reputational overhang.
What makes EVH unique
- Evolent's Performance Suite cross-sells imaging, oncology, and cardiology across existing payer clients.
- Its Q2 2026 revenue reached $652.5 million, showing scale in complex-condition management.
- The September 2025 Evolent Care Partners sale refocused capital on higher-margin specialty care.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
EVH is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →
About EVH
Simplify's Rating
Why EVH is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Design
Consumer Goods
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
EVH is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →